New Brunswick government reimburses Lucentis* for residents suffering from leading cause of age-related vision loss

Wet AMD patients now have access to first medication to improve vision and restore quality of life DORVAL, QC, Nov. 16 /CNW Telbec/ - New Brunswickers with wet age-related macular degeneration … [Read more...]

New Brunswick Covers Lucentis Treatments for Wet Macular Degeneration

Lucentis, the leading treatment for the eye disease wet macular degeneration is now covered through the New Brunswick Prescription Drug Plan (NBPDP).  The November 16 announcement ensures that people … [Read more...]

Avastin as Effective as Lucentis for Macular Degeneration

Avastin as effective as Lucentis for treating macular degeneration.  Researchers have shown that there is no difference between Avastin and Lucentis when used to treat macular … [Read more...]

Lucentis vs Avastin: Which Drug is Better?

Lucentis and Avastin are two drugs used as treatments for wet macular degeneration.  There has been considerable debate over which of these two treatments is best for treating macular degeneration.  … [Read more...]

British Columbia Approves Lucentis Funding for Macular Degeneration

Source - The Canadian Press VICTORIA, B.C. — The B.C. government will start funding two new drugs to treat people suffering from a disease that could cause blindness for seniors. Health … [Read more...]